{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:36:59Z","timestamp":1789612619828,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ahj.2018.05.018","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T13:32:52Z","timestamp":1533907972000},"page":"128-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study"],"prefix":"10.1016","volume":"204","author":[{"given":"Peter N\u00f8rkj\u00e6r","family":"Laursen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Holmvang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"L\u00f8nborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan E.","family":"H\u00f8fsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Helqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Clemmensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Kelb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Flensted","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frants","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"H\u00f8i-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Juhl","family":"Therkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Henrik","family":"Tilsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette Okkels","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Nepper-Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnaz","family":"Sadjadieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Engstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ahj.2018.05.018_bb0005","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJMoa1110717","article-title":"Comparative effectiveness of revascularization strategies","volume":"366","author":"Weintraub","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ahj.2018.05.018_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jval.2015.09.2938","article-title":"The \"efficacy-effectiveness gap\": historical background and current conceptualization","volume":"19","author":"Nordon","year":"2016","journal-title":"Value Health"},{"issue":"9453","key":"10.1016\/j.ahj.2018.05.018_bb0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: \"to whom do the results of this trial apply?\"","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ahj.2018.05.018_bb0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ije\/dyp174","article-title":"How to assess the external validity of therapeutic trials: a conceptual approach","volume":"39","author":"Dekkers","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ahj.2018.05.018_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"issue":"10","key":"10.1016\/j.ahj.2018.05.018_bb0030","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.amjcard.2010.06.070","article-title":"Comparison of baseline characteristics, management and outcome of patients with non\u2013ST-segment elevation acute coronary syndrome in versus not in clinical trials","volume":"106","author":"Hutchinson-Jaffe","year":"2010","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.018_bb0035","first-page":"632","article-title":"External validity of ST elevation myocardial infarction trials: the Zwolle studies","volume":"69","author":"Rasoul","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ahj.2018.05.018_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archinte.167.1.68","article-title":"External validity of clinical trials in acute myocardial infarction","volume":"167","author":"Steg","year":"2007","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ahj.2018.05.018_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1067\/mhj.2003.43","article-title":"Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry","volume":"145","author":"Bahit","year":"2003","journal-title":"Am Heart J"},{"issue":"17","key":"10.1016\/j.ahj.2018.05.018_bb0050","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/eurheartj\/ehr126","article-title":"Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants","volume":"32","author":"de Boer","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.05.018_bb0060","doi-asserted-by":"crossref","first-page":"g7064","DOI":"10.1136\/bmj.g7064","article-title":"Uncertainty and sampling error","volume":"349","author":"Altman","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2018.05.018_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/CLEP.S10190","article-title":"Existing data sources for clinical epidemiology: the Western Denmark Heart Registry","volume":"2","author":"Schmidt","year":"2010","journal-title":"Clin Epidemiol"},{"issue":"17","key":"10.1016\/j.ahj.2018.05.018_bb0070","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1308789","article-title":"Thrombus aspiration during ST-segment elevation myocardial infarction","volume":"369","author":"Frobert","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.018_bb0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ahj.2015.02.004","volume":"169","author":"Hofsten","year":"2015","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2018.05.018_bb0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ahj.2011.08.023","article-title":"Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitats Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design","volume":"163","author":"Jeger","year":"2012","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2018.05.018_bb0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ahj.2015.05.009","volume":"170","author":"Jensen","year":"2015","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.018_bb0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcin.2016.11.007","article-title":"Comparison of durable-polymer zotarolimus-eluting and biodegradable-polymer biolimus-eluting coronary stents in patients with coronary artery disease: 3-year clinical outcomes in the randomized SORT OUT VI trial","volume":"10","author":"Raungaard","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.ahj.2018.05.018_bb0095","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ahj.2013.08.025","volume":"166","author":"Steg","year":"2013","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.018_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"17","key":"10.1016\/j.ahj.2018.05.018_bb0105","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2018.05.018_bb0110","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0735-1097(01)01109-3","article-title":"Development and validation of the Ontario acute myocardial infarction mortality prediction rules","volume":"37","author":"Tu","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.05.018_bb0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.ahj.2018.05.018_bb0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.amjcard.2012.09.019","article-title":"Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial","volume":"111","author":"Fiocca","year":"2013","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2018.05.018_bb0125","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00392-016-0983-z","article-title":"External validity of the \"all-comers\" design: insights from the BIOSCIENCE trial","volume":"105","author":"Franzone","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2018.05.018_bb0130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2147\/CLEP.S99475","article-title":"The Danish Heart Registry","volume":"8","author":"Ozcan","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ahj.2018.05.018_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/CLEP.S44651","article-title":"Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology","volume":"5","author":"Thuesen","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.ahj.2018.05.018_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9149(99)80791-7","article-title":"Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study","volume":"76","author":"Kober","year":"1995","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ahj.2018.05.018_bb0145","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jacc.2013.01.007","article-title":"Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)","volume":"61","author":"Fokkema","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.018_bb0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/eurheartj\/ehi079","article-title":"The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice","volume":"26","author":"Flynn","year":"2005","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.018_bb0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrcardio.2015.33","article-title":"Registry-based randomized clinical trials\u2014a new clinical trial paradigm","volume":"12","author":"James","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2018.05.018_bb0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2288-7-30","article-title":"The Hawthorne effect: a randomised, controlled trial","volume":"3","author":"McCarney","year":"2007","journal-title":"BMC Med Res Methodol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:01:45Z","timestamp":1757570505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318302084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":31,"alternative-id":["S0002870318302084"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.05.018","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}